As you may recall from THIS story Floyd Landis was busted a few years ago during the 2006 Tour de France for using a performance enhancing drug.
That drug was testosterone.
Except that it really makes little sense for Landis to be using testosterone during the tour as the drug does little if anything to boost race day performance.
Most experts would agree that the main benefit of testosterone is during training when an athlete can recover faster and train harder while on testosterone.
Fast forward to today and the World Anti-Doping Agency Director General David Howman warned that international doping agencies need to do more to stop the spread of performance enhancing drugs in professional sports.
In THIS recent APF story Howman is quoted as saying:
"We are catching the dopey dopers, but not the sophisticated ones."
The story reports that, "while a total of 258,267 doping tests were carried out across the world last year, only 36 tests for the blood booster EPO came back positive after laboratory testing."
"It is the drug of choice for dopers," Howman said in reference to EPO.
"It is pathetic. We must increase quality and efficiency if we want to continue the fight."
We recently had a chance to sit down with Andrew Tilin, the author of the book The Doper Next Door.
In THIS fascinating interview Andrew talks about how performance enhancing drugs are no longer just for the pros. He also talks about the role that PED's play in professional cycling including touching on the both the Landis and Armstrong controversy.